Literature DB >> 28153560

Characteristics of patients with hospital-acquired influenza A (H1N1)pdm09 virus admitted to the intensive care unit.

F Álvarez-Lerma1, J Marín-Corral2, C Vilà3, J R Masclans4, I M Loeches5, S Barbadillo6, F J González de Molina7, A Rodríguez8.   

Abstract

BACKGROUND: Influenza A (H1N1)pdm09 virus infection acquired in the hospital and in critically ill patients admitted to the intensive care unit (ICU) has been poorly characterized. AIM: To assess the clinical impact of hospital-acquired infection with influenza A (H1N1)pdm09 virus in critically ill patients.
METHODS: Analysis of a prospective database of the Spanish registry (2009-2015) of patients with severe influenza A admitted to the ICU. Infection was defined as hospital-acquired when diagnosis and starting of treatment occurred from the seventh day of hospital stay with no suspicion on hospital admission, and community-acquired when diagnosis was established within the first 48 h of admission.
FINDINGS: Of 2421 patients with influenza A (H1N1)pdm09 infection, 224 (9.3%) were classified as hospital-acquired and 1103 (45.6%) as community-acquired (remaining cases unclassified). Intra-ICU mortality was higher in the hospital-acquired group (32.9% vs 18.8%, P < 0.001). Independent factors associated with mortality were hospital-acquired influenza A (H1N1)pdm09 infection (odds ratio: 1.63; 95% confidence interval: 1.37-1.99), APACHE II score on ICU admission (1.09; 1.06-1.11), underlying haematological disease (3.19; 1.78-5.73), and need of extrarenal depuration techniques (4.20; 2.61-6.77) and mechanical ventilation (4.34; 2.62-7.21).
CONCLUSION: Influenza A (H1N1)pdm09 infection acquired in the hospital is an independent factor for death in critically ill patients admitted to the ICU.
Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Community-acquired infections; Critically ill; H1N1 subtype; Infuenza A virus; Mortality; Nosocomial infection

Mesh:

Year:  2016        PMID: 28153560     DOI: 10.1016/j.jhin.2016.12.017

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  17 in total

1.  Understanding the role of host response in influenza pneumonitis.

Authors:  Benjamin M Tang; Carl G Feng; Anthony S McLean
Journal:  Intensive Care Med       Date:  2019-04-24       Impact factor: 17.440

2.  Evaluation of Influenza A H1N1 infection and antiviral utilization in a tertiary care hospital.

Authors:  Talita Rantin Belucci; Alexandre R Marra; Michael B Edmond; João Renato Rebello Pinho; Paula Kiyomi Onaga Yokota; Ana Carolina Cintra Nunes Mafra; Oscar Fernando Pavão Dos Santos
Journal:  BMC Infect Dis       Date:  2018-11-16       Impact factor: 3.090

3.  Influenza and associated co-infections in critically ill immunosuppressed patients.

Authors:  Ignacio Martin-Loeches; Virginie Lemiale; Pierce Geoghegan; Mary Aisling McMahon; Peter Pickkers; Marcio Soares; Anders Perner; Tine Sylvest Meyhoff; Ramin Brandt Bukan; Jordi Rello; Philippe R Bauer; Andry van de Louw; Fabio Silvio Taccone; Jorge Salluh; Pleun Hemelaar; Peter Schellongowski; Katerina Rusinova; Nicolas Terzi; Sangeeta Mehta; Massimo Antonelli; Achille Kouatchet; Pål Klepstad; Miia Valkonen; Precious Pearl Landburg; Andreas Barratt-Due; Fabrice Bruneel; Frédéric Pène; Victoria Metaxa; Anne Sophie Moreau; Virginie Souppart; Gaston Burghi; Christophe Girault; Ulysses V A Silva; Luca Montini; Francois Barbier; Lene B Nielsen; Benjamin Gaborit; Djamel Mokart; Sylvie Chevret; Elie Azoulay
Journal:  Crit Care       Date:  2019-05-02       Impact factor: 9.097

4.  Risk factors associated with severe outcomes in adult hospitalized patients according to influenza type and subtype.

Authors:  Ana Martínez; Núria Soldevila; Arantxa Romero-Tamarit; Núria Torner; Pere Godoy; Cristina Rius; Mireia Jané; Àngela Domínguez
Journal:  PLoS One       Date:  2019-01-11       Impact factor: 3.240

5.  Influenza A H1N1 Community-Acquired Pneumonia: Characteristics and Risk Factors-A Case-Control Study.

Authors:  Romina Abelleira; Alberto Ruano-Ravina; Adriana Lama; Gema Barbeito; María E Toubes; Cristina Domínguez-Antelo; Francisco J González-Barcala; Nuria Rodríguez-Núñez; Pedro J Marcos; María L Pérez Del Molino; Luis Valdés
Journal:  Can Respir J       Date:  2019-03-17       Impact factor: 2.409

6.  Dynamic changes of lymphocyte counts in adult patients with severe pandemic H1N1 influenza A.

Authors:  Yandong Cheng; Hong Zhao; Peixin Song; Zhaoping Zhang; Junhao Chen; Yi-Hua Zhou
Journal:  J Infect Public Health       Date:  2019-06-13       Impact factor: 3.718

7.  The spectrum of viral pathogens in children with severe acute lower respiratory tract infection: A 3-year prospective study in the pediatric intensive care unit.

Authors:  Ya-Ting Li; Ying Liang; Ye-Sheng Ling; Meng-Qi Duan; Li Pan; Zhuang-Gui Chen
Journal:  J Med Virol       Date:  2019-06-13       Impact factor: 2.327

8.  Hospital-acquired influenza infections detected by a surveillance system over six seasons, from 2010/2011 to 2015/2016.

Authors:  P Godoy; N Torner; N Soldevila; C Rius; M Jane; A Martínez; J A Caylà; A Domínguez
Journal:  BMC Infect Dis       Date:  2020-01-28       Impact factor: 3.090

Review 9.  Role of viral bioaerosols in nosocomial infections and measures for prevention and control.

Authors:  Yun-Hui Zhang; Nancy H L Leung; Benjamin J Cowling; Zi-Feng Yang
Journal:  J Aerosol Sci       Date:  2017-12-02       Impact factor: 3.433

10.  Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study.

Authors:  Gerard Moreno; Alejandro Rodríguez; Luis F Reyes; Josep Gomez; Jordi Sole-Violan; Emili Díaz; María Bodí; Sandra Trefler; Juan Guardiola; Juan C Yébenes; Alex Soriano; José Garnacho-Montero; Lorenzo Socias; María Del Valle Ortíz; Eudald Correig; Judith Marín-Corral; Montserrat Vallverdú-Vidal; Marcos I Restrepo; Antoni Torres; Ignacio Martín-Loeches
Journal:  Intensive Care Med       Date:  2018-08-03       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.